Design of a slide show aimed at explaining the working principle of their latest antiviral, Islatravir (anti-HIV).
Despite the discoveries of the last few years, often combined in the form of triple therapy, new strains resistant to nucleoside inhibitors (NRTI) are emerging.
Islatravir is the first translocation inhibitor applied to HIV treatment: explaining its completely innovative mechanism through small, simple animations was a true challenge. The project was carried out under the guidance of Dr Jean-Claude TARDY, Virologist at the Hospices Civils de Lyon.